KIM
Kestrel Investment Management’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-229,925
| Closed | -$6.58M | – | 44 |
|
|
2019
Q3 | $6.58M | Sell |
229,925
-1,950
| -0.8% | -$55.8K | 3.27% | 13 |
|
|
2019
Q2 | $6.44M | Sell |
231,875
-1,100
| -0.5% | -$30.6K | 3.05% | 14 |
|
|
2019
Q1 | $7.74M | Buy |
+232,975
| New | +$7.74M | 3.57% | 5 |
|
|
2015
Q2 | – | Sell |
-614,275
| Closed | -$21.7M | – | 49 |
|
|
2015
Q1 | $21.7M | Sell |
614,275
-26,100
| -4% | -$924K | 2.97% | 8 |
|
|
2014
Q4 | $21.8M | Sell |
640,375
-13,450
| -2% | -$458K | 2.91% | 10 |
|
|
2014
Q3 | $25.2M | Sell |
653,825
-22,900
| -3% | -$883K | 3.57% | 5 |
|
|
2014
Q2 | $26.3M | Sell |
676,725
-12,000
| -2% | -$467K | 3.28% | 5 |
|
|
2014
Q1 | $23.5M | Sell |
688,725
-10,825
| -2% | -$370K | 2.92% | 10 |
|
|
2013
Q4 | $14.7M | Sell |
699,550
-154,925
| -18% | -$3.25M | 1.81% | 24 |
|
|
2013
Q3 | $20.1M | Buy |
+854,475
| New | +$20.1M | 2.06% | 20 |
|